Laboratory study demonstrates rapid metformin detection using molecularly imprinted polymer liquid electrodes, indicating potential for simplified pharmaceutical quality control without sample...
Metformin (MEF) imprinted polymer liquid electrodes arecreated using a precipitation polymerization process. The MEF served as a template for the creation of molecularly imprinted (MIP) materials using benzoyl peroxide (BPO) as an initiator, allyl methacrylate (AMA) crosslinkers, and glycidyl methacrylate (GMA) as a monomer. UtilizingDi-octyl-phthalate (DOPH) and di-butyl phthalate (DBPH) as plasticizers in a PVC matrix, the molecularly imprinted membranes arecreated. The reaction time is approximately 50 seconds, and the limits of detection for liquid electrodes, as determined by the calibration curves, are 55.6 to 58.4 mV/decadeat 5×10-5M and 8×10-5M respectively. The liquid electrodes demonstrated good selectivity over a variety of species and a consistent reaction when filled with a typical 0.1 M drug solution across the pH range of 1 to 11. Modern electrodes can detect MEF without the need for time-consuming pre-treatment procedures in pharmaceutical samples.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: